Cargando…
SUMOylation of AnxA6 facilitates EGFR-PKCα complex formation to suppress epithelial cancer growth
BACKGROUND: The Annexin A6 (AnxA6) protein is known to inhibit the epidermal growth factor receptor (EGFR)-extracellular signal regulated kinase (ERK)1/2 signaling upon EGF stimulation. While the biochemical mechanism of AnxA6 inactivating phosphorylation of EGFR and ERK1/2 is not completely explore...
Autores principales: | Sheng, Zenghua, Cao, Xu, Deng, Ya-nan, Zhao, Xinyu, Liang, Shufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391975/ https://www.ncbi.nlm.nih.gov/pubmed/37528485 http://dx.doi.org/10.1186/s12964-023-01217-x |
Ejemplares similares
-
Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer
por: Gibbs, Lee D., et al.
Publicado: (2017) -
The Essential Role of anxA2 in Langerhans Cell Birbeck Granules Formation
por: Thornton, Shantae M., et al.
Publicado: (2020) -
Apigenin Modulates AnxA6- and TNAP-Mediated Osteoblast Mineralization
por: Mroczek, Joanna, et al.
Publicado: (2022) -
AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE(−/−) mice
por: Burgmaier, Mathias, et al.
Publicado: (2014) -
SUMOylation modification-mediated cell death
por: Sheng, Zenghua, et al.
Publicado: (2021)